A detailed history of Caption Management, LLC transactions in Novavax Inc stock. As of the latest transaction made, Caption Management, LLC holds 240,000 shares of NVAX stock, worth $2.16 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
240,000
Previous 100,000 140.0%
Holding current value
$2.16 Million
Previous $1.27 Million 139.42%
% of portfolio
0.05%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.89 - $20.97 $37,725 - $203,367
-9,698 Reduced 44.7%
12,000 $151,000
Q1 2024

May 15, 2024

BUY
$3.76 - $6.02 $81,584 - $130,621
21,698 New
21,698 $103,000
Q2 2021

Aug 16, 2021

SELL
$121.0 - $257.67 $931,700 - $1.98 Million
-7,700 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$112.98 - $319.93 $869,946 - $2.46 Million
7,700 New
7,700 $1.4 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.